Technology Complexity and Open Organization: Foreign Innovation Projects in the Biopharmaceutical Sector in China

High technology organizations are increasingly facing survival and growth challenges. Whereas the investment in R and D projects is increasing; the development of the new product is decreasing in the biopharmaceutical sector [1]. The pressure for the productivity and emerging opportunities from changing institutions as well as from the advent of enabling information and communication technologies are pushing firms to manage their R and D projects efficiently and effectively around the world. In doing so, high technology firms are attempting to avail opportunities in foreign countries that are not available at in the home market. Thus, the arising need for and opportunities from the changing environment have disturbed two established assumptions in the organizational literature.